Publicity of the results of the second batch of procurement with volume to be selected, with an average decrease of 53%
-
Last Update: 2020-01-19
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 17, the second batch of state-organized drug centralized procurement was carried out in Shanghai, and the results of the proposed selection were announced late on January 17 32 of the 33 varieties of this centralized procurement were successfully purchased, with a total of 100 products selected 122 enterprises participated, and 77 enterprises were proposed to be selected Compared with the lowest purchase price in 2018 in the alliance region, the average price of the proposed mid-term selection will be reduced by 53%, and the maximum price will be reduced by 93% In particular, the large price reduction of the regular drugs for chronic diseases such as acarbose and glimepiride will significantly reduce the burden of patients The results will be officially released three days after the announcement, and it is expected to let patients from all over the country use this batch of price reducing drugs in April Appendix: the results of the national drug centralized procurement plan PDF 37
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
